LUCD News and Press, Lucid Diagnostics Inc. From 07/16/25

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire Virtual public CAC meeting to be held September 4, 2025 , at 2:00 p.m. ET NEW YORK , July 16, 20...

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire Lucid to partner with Hoag in its mission to eradicate esophageal cancer by expanding access to EsoGuard precancer...

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes PR Newswire NEW YORK , May 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostic...

PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire Lucid secured capital to extend runway well past key upcoming reimbursement milestones; ended 1Q25 with over $40 million in proforma cash Veris Health completed 1Q25 financ...

2025-05-14 13:52:45 ET More on Lucid Diagnostics Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript Lucid Diagnostics Inc. (LUCD) Q4 2024 Earnings Call Transcript Lucid Diagnostics Inc. 2024 Q4 - Results - Earnings Call Presentation PAVmed,...

2025-05-14 13:51:56 ET Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Conference Call May 14, 2025 8:30 AM ET Company Participants Matt Riley – Senior Director-Investor Relations Lishan Aklog – Chairman and Chief Executive Officer Dennis McGr...

2025-05-14 08:51:40 ET More on Lucid Diagnostics PAVmed, Lucid post encouraging results from EsoGuard study Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering Seeking Alpha’s Quant Rating on Lucid Diagnostics Read th...

Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results PR Newswire Processed 3,034 EsoGuard ® tests and recognized revenue of $0.8 million in 1Q25 Secured capital to extend runway well past key upcoming reimbursement mi...

Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...

2025-05-13 18:48:09 ET Lucid Diagnostics Inc. (LUCD) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 3.98%. The average open to low on the day of earnings was -6.38%. The average open to...